Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
Protein-coding genes represent only a small fraction of the human genome. In the past, the majority of the genomic sequence has been considered transcriptionally silent, but recent large-scale studies have uncovered an array of functionally significant elements, including non-protein-coding transcri...
Main Authors: | Fatjon Leti, Johanna K. DiStefano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/8/8/207 |
Similar Items
-
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
by: Jun Wei, et al.
Published: (2021-08-01) -
Promising Directions in Atherosclerosis Treatment Based on Epigenetic Regulation Using MicroRNAs and Long Noncoding RNAs
by: Daria Skuratovskaia, et al.
Published: (2019-06-01) -
Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation
by: Yating Sun, et al.
Published: (2017-10-01) -
Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments
by: Olga Khorkova, et al.
Published: (2021-04-01) -
Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material
by: Hiroki Tanaka, et al.
Published: (2021-04-01)